Search

Your search keyword '"Soft Tissue Infections epidemiology"' showing total 832 results

Search Constraints

Start Over You searched for: Descriptor "Soft Tissue Infections epidemiology" Remove constraint Descriptor: "Soft Tissue Infections epidemiology"
832 results on '"Soft Tissue Infections epidemiology"'

Search Results

1. Methicillin-resistant Staphylococcus aureus in diabetic and non-diabetic foot infections.

2. Clinical outcomes in people with diabetes-related foot infections: Analysis from a limb preservation service infection database.

3. Pathogenomic profile and clonal diversity of potential zoonotic MRSA-CC7-ST789-t091-SCCmecV from human skin and soft tissue infections.

4. Skin and Soft Tissue Actinomycosis in Children and Adolescents.

5. Association between Insurance Status and Outcomes of Hospitalizations for Necrotizing Soft Tissue Infections.

6. The interplay between diabetes Mellitus and soft tissue infections in general surgical patients.

7. MRSA infection, re-infection and clinical outcomes in diabetic foot infections.

8. The bacterial profile and antibiotic susceptibility in skin and soft tissue infections at a tertiary care hospital of Quetta, Pakistan.

9. Epidemiology and clinical features of Skin and Soft Tissue Infections Caused by PVL-Positive and PVL-Negative Methicillin-Resistant Staphylococcus aureus Isolates in inpatients in China: a single-center retrospective 7-year study.

10. Temporal trends of skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus in Gabon.

11. Staphylococcus aureus carriage and prevalence of skin and soft tissue infections among people who inject drugs: a longitudinal study.

12. Skin and soft tissue infections in solid organ transplants.

13. Necrotizing fasciitis: an update on epidemiology, diagnostic methods, and treatment.

14. Risk model for predicting mortality in patients with necrotizing soft tissue infections in the intensive care unit.

15. The burden of skin and soft tissue, bone and joint infections in an Australian cohort of people who inject drugs.

16. [Pediatric necrotizing soft-tissue infections].

17. Bacterial Skin and Soft Tissue Infections in Older Adults.

18. Community-acquired Staphylococcus aureus skin and soft tissue infection risk assessment using hotspot analysis and risk maps: the case of California emergency departments.

19. Doxycycline Prophylaxis for Skin and Soft Tissue Infections in Naval Special Warfare Trainees, United States 1 .

20. Epidemiology of acute infections in people who inject drugs in Australia.

21. Skin and soft tissue infection incidence before and during the COVID-19 pandemic.

22. A prospective study on skin and soft tissue infections: a fact-finding mission from a tertiary centre in north India.

23. Molecular Epidemiology and Virulence Gene Analysis of Methicillin-Resistant Staphylococcus aureus Associated with Skin and Soft Tissue Infections in the Shaoxing Region.

24. Antimicrobial treatment of skin and soft tissue infections.

25. Non-tuberculous mycobacterial skin and soft tissue infections in the Northern Territory, Australia, 1989-2021.

26. Severe and complicated soft tissue infections: a single-centre case series.

27. Antibiotic susceptibility and clonal distribution of Staphylococcus aureus from pediatric skin and soft tissue infections: 10-year trends in multicenter investigation in China.

28. Risk factors for deep neck infection in patients with sore throat and neck pain.

29. First-year recurrence rate of skin and soft tissue infections following an initial necrotizing soft tissue infection of the lower extremities: A retrospective cohort study of 93 patients.

30. Does a Positive Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screen Predict the Risk for MRSA Skin and Soft Tissue Infection?

31. Skin and Soft Tissue Infections in Young Infants.

32. Skin and soft tissue infections in the elderly.

33. Genomic Characterization of Skin and Soft Tissue Streptococcus pyogenes Isolates from a Low-Income and a High-Income Setting.

34. Infections in patients with adverse reactions to the use of unknown modeling substances for soft tissue enhancement in Cali, Colombia.

35. [Diagnosis of severe skin infections, epidemiology and clinical semiology].

36. The second nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan.

37. Risk stratification system for skin and soft tissue infections after allogeneic hematopoietic stem cell transplantation: PAH risk score.

38. Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry.

39. Sequence types 8, 59, and 45 methicillin resistant Staphylococcus aureus as the predominant strains causing skin and soft tissue infections in Taiwan's prisons and jails.

40. Re-Admission in Patients with Necrotizing Soft Tissue Infections: Continuity of Care Matters.

41. Understanding the Prodromal Period of Necrotizing Soft Tissue Infections of the Genitalia (Fournier's Gangrene) and the Incidence, Duration, and Risk Factors Associated With Potential Missed Opportunities for an Earlier Diagnosis: A Population-based Longitudinal Study.

42. Panton-Valentine leucocidin-producing Staphylococcus aureus: a clinical review.

43. Extensive Subcutaneous Abscess due to Panton-Valentine Leucocidin-Positive Community-Associated Methicillin-Resistant Staphylococcus aureus in an Infant.

44. [Methicillin-resistant Staphylococcus aureus in wound drainage in children]

45. Comorbidities Matter as Distressed Communities Index Fails to Predict Mortality in Necrotizing Soft Tissue Infection.

46. Decision support system and outcome prediction in a cohort of patients with necrotizing soft-tissue infections.

47. Frequency and Antibiotic Susceptibility Pattern of Community-associated Methicillin-resistant <em>Staphylococcus Aureus</em> (CA-MRSA) in Uncomplicated Skin and Soft Tissue Infections.

48. Reduced Emergency Department Visits and Hospitalisation with Use of an Unsanctioned Safe Consumption Site for Injection Drug Use in the United States.

49. Impact of Comorbidities on the Cause of Death by Necrotizing Soft Tissue Infections.

50. Bacteriological profile of paediatric skin and soft tissue infections and their antibiogram at a tertiary care teaching hospital in north India.

Catalog

Books, media, physical & digital resources